04/25/2025
5:56 AM | Cullinan Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
5:58 AM | Cullinan Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
6:00 AM | Cullinan Therapeutics (Filer)
| Form ARS | |
02/27/2025
4:00 PM | Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:00 PM | AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:00 PM | Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:03 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:07 AM | Cullinan Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:11 AM | Cullinan Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CGEM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cullinan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:00 PM | Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
5:00 PM | AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
6:00 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
4:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:22 PM | Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
5:00 PM | AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:00 PM | Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:00 PM | Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:00 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
1:23 PM | Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/07/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:06 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:18 AM | Cullinan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
10:18 AM | Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024
11:48 AM | Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G | |
10/16/2024
6:17 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
6:13 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:27 PM | Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
5:00 PM | Cullinan Therapeutics (Issuer)
Thistle Mary (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/08/2024
6:20 AM | Cullinan Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:15 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:19 PM | Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
07/02/2024
6:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Cullinan Therapeutics (Issuer)
Ryan David P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Cullinan Therapeutics (Issuer)
Martin Anne-Marie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Cullinan Therapeutics (Issuer)
Rosenberg Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:00 PM | Cullinan Therapeutics (Issuer)
Webster Stephen W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:00 PM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
5:00 PM | Cullinan Therapeutics (Issuer)
Ebeling Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
12:30 PM | BlackRock Inc. (Filed by)
Cullinan Therapeutics (Subject)
| Form SC 13G/A | |
06/04/2024
11:15 PM | Cullinan Therapeutics (Filer)
| Form EFFECT | |
06/03/2024
7:12 AM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
4:07 PM | Cullinan Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:40 PM | Cullinan Therapeutics (Issuer)
Meek David D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
4:30 PM | Cullinan Therapeutics (Issuer)
Meek David D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2024
6:30 AM | Cullinan Therapeutics (Filer)
| Form ARS | |
05/16/2024
5:42 AM | Cullinan Therapeutics (Filer)
| Form DEFA14A | |
05/16/2024
5:40 AM | Cullinan Therapeutics (Filer)
| Form DEF 14A | |
05/08/2024
6:30 PM | Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:32 PM | Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
